Skip to Content

RAPAMUNE 0.5 mg (Rapamune 0.5 mg)

Generic Name: sirolimus

Pill with imprint RAPAMUNE 0.5 mg is Tan, Three-sided and has been identified as Rapamune 0.5 mg. It is supplied by Wyeth Laboratories.

Rapamune is used in the treatment of lymphangioleiomyomatosis; organ transplant, rejection prophylaxis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Rapamune 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RAPAMUNE 0.5 mg

Rapamune

Generic Name
sirolimus
Imprint
RAPAMUNE 0.5 mg
Strength
0.5 mg
Color
Tan
Size
8.00 mm
Shape
Three-sided
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Wyeth Laboratories
Inactive Ingredients
sucrose, polyethylene glycol 8000, microcrystalline cellulose, magnesium silicate, titanium dioxide, magnesium stearate, povidone k30, lactose monohydrate, poloxamer 188, carnauba wax, ferric oxide yellow, alpha tocopherol acetate, glyceryl oleate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00008-1040 Wyeth
59762-1001 Greenstone LLC

Get help with Imprint Code FAQs.

Related Images for "RAPAMUNE 0.5 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.